The Central Drugs Standard Control Organisation (CDSCO) has clarified that there are no changes to the sales and distribution of emergency contraceptive pills such as i-Pill and Unwanted-72. The proposed amendments to the Drug Rules aim to clarify existing regulations and will not impact the availability of these pills over-the-counter.
The Central Drugs Standard Control Organisation (CDSCO) in India has issued an alert regarding 50 commonly used medicines found to be of substandard quality in August 2024. The list includes popular brands like Pan-D, Paracetamol, blood pressure medications, and diabetes drugs, manufactured by companies like Unicure India Ltd, Hetero Drugs, and Alkem Laboratories. The CDSCO also identified five drugs as spurious, adulterated, or misbranded.
India’s drug regulator, CDSCO, has flagged over 50 popular medications, including Paracetamol and Pan D, for failing to meet safety and quality standards. This revelation has raised concerns about drug safety in India, with several pharmaceutical companies denying responsibility for the substandard drugs.
